{"id":"https://openalex.org/W2980413699","doi":"https://doi.org/10.1016/j.jalz.2019.06.3690","title":"P4\u2010031: MALLEABILITY OF AGING PROCESSES VIA PLASMA BASED THERAPEUTICS","display_name":"P4\u2010031: MALLEABILITY OF AGING PROCESSES VIA PLASMA BASED THERAPEUTICS","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W2980413699","doi":"https://doi.org/10.1016/j.jalz.2019.06.3690","mag":"2980413699"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2019.06.3690","doi":"https://doi.org/10.1016/j.jalz.2019.06.3690","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2019.06.3690","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037456393","display_name":"Steven P. Braithwaite","orcid":"https://orcid.org/0000-0003-0520-8823","observed_orcids":["https://orcid.org/0000-0003-0520-8823"]},"institutions":[{"id":"https://openalex.org/I4405267265","display_name":"Alkahest, Inc. (United States)","ror":"https://ror.org/01y7mep45","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267265"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Steven P. Braithwaite","raw_affiliation_strings":["Alkahest, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkahest, Inc., San Carlos, CA, USA","institution_ids":["https://openalex.org/I4405267265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109095297","display_name":"Viktoria Kheifets","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267265","display_name":"Alkahest, Inc. (United States)","ror":"https://ror.org/01y7mep45","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Viktoria Kheifets","raw_affiliation_strings":["Alkahest, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkahest, Inc., San Carlos, CA, USA","institution_ids":["https://openalex.org/I4405267265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075620744","display_name":"Eva Czirr","orcid":"https://orcid.org/0000-0003-0247-0631","observed_orcids":["https://orcid.org/0000-0003-0247-0631"]},"institutions":[{"id":"https://openalex.org/I4405267265","display_name":"Alkahest, Inc. (United States)","ror":"https://ror.org/01y7mep45","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eva Czirr","raw_affiliation_strings":["Alkahest, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkahest, Inc., San Carlos, CA, USA","institution_ids":["https://openalex.org/I4405267265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074247756","display_name":"Meghan Kerrisk Campbell","orcid":"https://orcid.org/0000-0003-4906-7743","observed_orcids":["https://orcid.org/0000-0003-4906-7743"]},"institutions":[{"id":"https://openalex.org/I4405267265","display_name":"Alkahest, Inc. (United States)","ror":"https://ror.org/01y7mep45","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meghan K. Campbell","raw_affiliation_strings":["Alkahest, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkahest, Inc., San Carlos, CA, USA","institution_ids":["https://openalex.org/I4405267265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038986295","display_name":"Ian Gallager","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267265","display_name":"Alkahest, Inc. (United States)","ror":"https://ror.org/01y7mep45","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ian Gallager","raw_affiliation_strings":["Alkahest, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkahest, Inc., San Carlos, CA, USA","institution_ids":["https://openalex.org/I4405267265"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021110313","display_name":"Sakura Minami","orcid":"https://orcid.org/0000-0001-8505-4486","observed_orcids":["https://orcid.org/0000-0001-8505-4486"]},"institutions":[{"id":"https://openalex.org/I4405267265","display_name":"Alkahest, Inc. (United States)","ror":"https://ror.org/01y7mep45","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Sakura Minami","raw_affiliation_strings":["Alkahest, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkahest, Inc., San Carlos, CA, USA","institution_ids":["https://openalex.org/I4405267265"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5037456393"],"corresponding_institution_ids":["https://openalex.org/I4405267265"],"apc_list":{"value":3150,"currency":"USD","value_usd":3150},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.16037553,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"15","issue":"7S_Part_24","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.5019999742507935,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.5019999742507935,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10676","display_name":"Genetics, Aging, and Longevity in Model Organisms","score":0.12210000306367874,"subfield":{"id":"https://openalex.org/subfields/1302","display_name":"Aging"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13446","display_name":"Antioxidants, Aging, Portulaca oleracea","score":0.07039999961853027,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parabiosis","display_name":"parabiosis","score":0.7129999995231628}],"concepts":[{"id":"https://openalex.org/C87753298","wikidata":"https://www.wikidata.org/wiki/Q17157137","display_name":"Neuroinflammation","level":3,"score":0.6784921288490295},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.6296207308769226},{"id":"https://openalex.org/C4746552","wikidata":"https://www.wikidata.org/wiki/Q1456827","display_name":"Neurogenesis","level":2,"score":0.5174477696418762},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.48941507935523987},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.43352001905441284},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.4194566011428833},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3926379084587097},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3866689205169678},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3417324423789978},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3215039074420929},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15722110867500305}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2019.06.3690","doi":"https://doi.org/10.1016/j.jalz.2019.06.3690","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2019.06.3690","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2948514534","https://openalex.org/W2981293968","https://openalex.org/W2983804858","https://openalex.org/W2896173418","https://openalex.org/W4200276486","https://openalex.org/W2800497740","https://openalex.org/W2589853612","https://openalex.org/W2756551061","https://openalex.org/W3032895985","https://openalex.org/W2518475808"],"abstract_inverted_index":{"Age":[0],"is":[1,55],"the":[2,10,185,217],"major":[3],"risk":[4,33],"factor":[5],"for":[6,35,52,77,170,246],"Alzheimer's":[7,230],"disease":[8],"and":[9,28,44,68,89,96,103,106,137,164,201],"majority":[11],"of":[12,31,110,122,145,154,173,180,196,224],"neurodegenerative":[13],"disorders.":[14],"Being":[15],"able":[16],"to":[17,80,118,130,138,219,240],"modulate":[18,81,220],"fundamental":[19,207],"aging":[20,39],"processes":[21,40],"may":[22],"therefore":[23],"have":[24,189],"broad":[25,108,120,206],"therapeutic":[26,53,61],"utility":[27],"act":[29],"upstream":[30],"other":[32],"factors":[34],"disease.":[36,231],"Whether":[37],"biological":[38],"can":[41,49],"be":[42,50],"reversed,":[43],"whether":[45],"multiple":[46,221],"age-related":[47,227],"mechanisms":[48,121,223],"impacted":[51],"benefit,":[54],"a":[56,107,143,171],"challenging":[57],"proposition":[58],"through":[59],"traditional":[60],"routes.":[62],"Building":[63],"on":[64],"understandings":[65],"from":[66],"parabiosis":[67],"plasma":[69,73,126,149,210],"infusions,":[70],"therapeutically":[71],"viable":[72],"fractions":[74,233],"were":[75,168],"tested":[76],"their":[78],"ability":[79,218],"CNS-relevant":[82],"endpoints":[83],"in":[84,85,90,99,113,134,142,152,184,192,226],"vitro":[86],"cell":[87],"culture":[88],"vivo":[91],"systems.":[92],"Testing":[93],"synaptic/network":[94],"activity":[95,133,155],"morphology":[97],"measurements":[98],"primary":[100],"neuronal":[101,135],"cultures":[102,136],"cognitive":[104,140],"behavior":[105],"array":[109],"histological":[111],"analyses":[112],"aged":[114],"mice":[115,197],"was":[116,128,177],"performed":[117],"assess":[119],"action.":[123],"A":[124,209],"prioritized":[125],"fraction":[127,150,211],"demonstrated":[129,191],"enhance":[131,139],"network":[132],"performance":[141],"range":[144],"behavioral":[146],"paradigms.":[147],"The":[148],"resulted":[151],"enhancement":[153],"as":[156,243],"indicated":[157],"by":[158],"elevated":[159],"cfos":[160],"expression,":[161],"reduced":[162],"neuroinflammation":[163],"enhanced":[165],"neurogenesis.":[166],"Effects":[167],"maintained":[169],"period":[172],"months":[174],"after":[175],"dosing":[176],"completed,":[178],"indicative":[179],"long":[181],"term":[182],"efficacy":[183],"brain.":[186],"Beneficial":[187],"activities":[188],"been":[190,213],"three":[193],"independent":[194],"lines":[195],"-":[198,204],"C57Bl6,":[199],"NSG":[200],"\u03b1-synuclein":[202],"transgenics":[203],"demonstrating":[205],"activity.":[208],"has":[212,216],"identified":[214],"that":[215],"underlying":[222],"relevance":[225],"disorders":[228],"including":[229],"These":[232],"are":[234],"being":[235],"advanced":[236],"into":[237],"clinical":[238],"testing":[239],"understand":[241],"potential":[242],"transformative":[244],"therapeutics":[245],"patients.":[247]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2019-10-25T00:00:00"}